HK$49.70
+
HK$0.50 (1.02%)
End-of-day quote: 05/16/2024
SEHK:9926
Akeso Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | NYSE | Outperform | $130.88 | $130.51 | 0.00% | 11 | $331.49B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.11 | $58.15 | 0.00% | 10 | $89.42B |
| BGNE | BeiGene | NasdaqGS | Buy | $171.03 | $285.19 | 0.00% | 2 | $17.89B |
| 1801 | Innovent Biologics | SEHK | Buy | HK$39.80 | HK$50.72 | 0.00% | 6 | HK$65.98B |
| 300003 | Lepu Medical Technology (Beiji... | SZSE | Buy | ¥16.05 | ¥25.02 | 0.00% | 3 | ¥28.70B |
| 1877 | Shanghai Junshi Biosciences | SEHK | Outperform | HK$13.78 | HK$31.29 | 0.00% | 1 | HK$28.37B |
| 2696 | Shanghai Henlius Biotech | SEHK | Outperform | HK$18.20 | HK$14.18 | 0.00% | 0 | HK$8.87B |
